Laser‑Driven Phase Contrast Enhances Cryo‑EM Resolution of Small Proteins
Credit: Christoph Burgstedt/Science Photo Library/Getty Images You know when you are at the eye doctor getting an updated…
Silver nanoparticles enable precise DNA cutting and assembly
DNA is composed of long chains that act as the blueprint for living organisms. In genetic engineering, scientists…
Is the peptide craze backed by science? The promise behind the hype
Peptides have become the latest cure-all trend on social media — a way to eliminate wrinkles, build lean…
Middle East Erupts Again: Buy these Healthcare ETFs Before the Next Strike
The global geopolitical landscape has plunged into a deep state of uncertainty once again following a direct exchange…
Study potentially opens a new route to more selective cancer drug design
Researchers at the Icahn School of Medicine at Mount Sinai have identified a previously hidden druggable site in…
Recursion Pharmaceuticals vs. Schrödinger: Which Healthcare Stock Is a Better Buy in 2026?
As drug discovery moves from trial-and-error to digital simulation, choosing between Recursion Pharmaceuticals (NASDAQ:RXRX) and Schrödinger (NASDAQ:SDGR) depends…
Pluvicto™ demonstrated consistent efficacy across key patient subgroups in metastatic hormone-sensitive prostate cancer
Improved radiographic progression-free survival (rPFS) regardless of disease volume or metastatic presentation achieved with Pluvicto plus standard of…
AI Designs Miniprotein Switches for GPCR Targeting
Credit: Juan Gaetner/ Getty Images / Science Photo Library Many scientists first encountered G protein–coupled receptors (GPCRs) as…
Cyclana Bio granted Health Research Authority approval and recruits first patients for clinical observational study in endometriosis
Cyclana Bio, a biotechnology company pioneering tissue-level approaches to women’s health, today announced it has received Health Research…
7 Healthcare AI Stocks Under $50 With Huge Upside Potential
Quick Read Dislocation between share price and product progress is exactly the kind of setup retail investors should…
New PSMAddition data show 58% lower risk of PSA progression with Pluvicto® in metastatic hormone-sensitive prostate cancer
More durable, deeper PSA response in patients treated with Pluvicto plus standard of care (ARPI + ADT) vs.…
Targeting Undruggable Proteins With A Molecular Glue
Researchers at the Canadian Light Source have discovered a molecular glue that can bind two proteins together and…